immatics biotechnologies GmbH (IMTXW) — Free Cash Flow Generation Index

Latest as of December 2023: 0.88x

immatics biotechnologies GmbH (IMTXW) has a Free Cash Flow Generation Index of 0.88x as of December 2023. Free cash flow of $69.78 Million represents 1% of operating cash flow ($79.08 Million). Explore how much does immatics biotechnologies GmbH reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.88x
Free Cash Flow / Operating CF

Free Cash Flow

$69.78 Million
USD

Operating Cash Flow

$79.08 Million
USD

Capital Expenditures

$9.29 Million
USD

immatics biotechnologies GmbH Free Cash Flow Generation Index (2018–2023)

Historical FCF Generation Index trend for immatics biotechnologies GmbH across 4 annual periods. For the full cash flow conversion analysis, see IMTXW cash generation efficiency.

Annual Free Cash Flow Generation for immatics biotechnologies GmbH (2018–2023)

Year-by-year Free Cash Flow Generation Index for immatics biotechnologies GmbH. Check immatics biotechnologies GmbH total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2023 -0.70x $-12.73 Million $18.23 Million $30.96 Million ▼ -174.5%
2022 0.94x $93.92 Million $100.13 Million $6.21 Million ▼ -3.2%
2019 0.97x $68.73 Million $70.97 Million $2.23 Million ▼ -0.7%
2018 0.98x $20.18 Million $20.68 Million $507.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).